Eileen Chambers is a Nephrology physician affiliated with Duke University. OpenAlex indexes 49 publications with 466 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 Erwin Rd
Durham, NC 277054699
Telephone
919-684-4246Registry record last updated 9 May 2016.
Clinical trials
- Advancing Transplantation Outcomes in Children
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
Sponsor: Duke University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20253 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- Novo Nordisk Health Care AGProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
31.7%H2 blocker15%Famotidine100%Part D<11 patientsOsmotically acting laxatives9%Magnesium Sulfate100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
25.7%Calcineurin inhibitor25.7%Tacrolimus74%Envarsus Xr26%Part D<11 patientsAnti-infectives
19.8%Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor19.8%Valganciclovir Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Tailored mHealth Coaching and Social Resource Support to Reduce Health Disparities in Kidney Transplantation
Duke University
FY2026$771,059R01MD020306 - Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejection
Duke University
FY2022$241,500R21HD102790 - Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejection
Duke University
FY2021$201,250R21HD102790
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS
Nephrology Dialysis Transplantation
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Califf, MD
Duke University
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
John Perfect, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”